## NTRS: Northern Trust Corporation - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.1% in lower entry zone (3.0-6.0%), top quartile (78th pct) cross-sectional ranking. Short-term MRS_5 (3.0%) confirms momentum alignment. Strong momentum (+3.7% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($138.88)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. northern trust corporation stock hits all-time high at 141.4 usd By Investing.com**
- Source: Investing.com South Africa | 20260105T150331 | Bullish | Relevance: 100%
- Northern Trust Corporation (NTRS) stock has reached an all-time high of $141.4, reflecting a 38.67% increase over the past year. The financial services company has maintained dividend payments for 55 consecutive years with a 2.3% dividend yield, and is considered slightly undervalued according to InvestingPro's Fair Value assessment. Recent developments include leadership changes, new debt securities, a decreased prime rate, and a new partnership for middle office support services.

**2. northern trust corporation stock hits all-time high at 141.4 usd**
- Source: Investing.com | 20260105T160830 | Bullish | Relevance: 100%
- Northern Trust Corporation (NTRS) stock has reached an all-time high of $141.4, marking a 38.67% increase over the past year. InvestingPro notes the company's 55-year dividend payment streak and a current 2.3% dividend yield, with the stock appearing slightly undervalued according to their Fair Value assessment. The company has also announced leadership changes, issued new debt, decreased its prime rate, and secured new middle office support contracts.

**3. Seeking Clues to Northern Trust (NTRS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics**
- Source: MSN | 20260104T140811 | Neutral | Relevance: 100%
- This article examines Wall Street's expectations for Northern Trust's (NTRS) Q2 earnings, focusing on key metrics like revenues and earnings per share. Analysts predict a decline in both figures compared to the prior-year quarter, providing insights into potential upcoming financial performance.

**4. Northern Trust Corporation $NTRS Shares Sold by Financiere des Professionnels Fonds d investissement inc.**
- Source: MarketBeat | 20260103T140911 | Neutral | Relevance: 100%
- Financiere des Professionnels Fonds dâ€™investissement inc. reduced its stake in Northern Trust Corporation (NASDAQ: NTRS) by 26.4% in the third quarter, selling 21,374 shares and now owning 59,706 shares valued at approximately $8.04 million. Insider activity for Northern Trust was mixed, with Director Robert Edward Jr. Moritz purchasing 3,891 shares while EVP Susan Cohen Levy sold 27,591 shares on the same day. Northern Trust reported strong quarterly earnings, beating analyst estimates, and maintained a dividend payout of $0.80 per share.

**5. Cwm LLC Acquires 8,452 Shares of Northern Trust Corporation $NTRS**
- Source: MarketBeat | 20260103T102126 | Somewhat-Bullish | Relevance: 100%
- Cwm LLC increased its stake in Northern Trust Corporation by 63.8% in Q3, acquiring 8,452 additional shares and bringing their total holdings to 21,690 shares valued at approximately $2.92 million. Northern Trust (NASDAQ:NTRS) recently beat Q3 earnings estimates, reporting $2.29 EPS on $2.03 billion revenue, and declared a quarterly dividend of $0.80 per share. Institutional investors hold 83.19% of the stock, while analysts currently rate it as "Hold" with a consensus target price of $133.08.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Barclays | $160 | $136 | +18% |
| 2025-12-30 | Citigroup | $143 | $135 | +6% |
| 2025-12-17 | Morgan Stanley | $131 | $127 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Barclays | main | Equal-Weight |
| 2025-12-30 | Citigroup | main | Neutral |
| 2025-12-17 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($2.14M) |
| Sells | 12 ($1.57M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-1.3%)
- FMR, LLC: 8.3% (-9.9%)
- Blackrock Inc.: 7.9% (-1.4%)
- State Street Corpora: 5.0% (+1.0%)
- Primecap Management : 4.0% (-3.2%)

### Key Risks

1. Valuation stretched: PEG 6.9x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +9%) could attract flows.
- Momentum building: MRS_10 improving +3.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 6.94 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 22%). Analyst sentiment positive (3 raises, avg +9%). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $27.5B |
| Beta | 1.28 |
| 52W Range | $81.62 - $144.90 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.94 |
| Forward P/E | 15.4 |
| Current P/E | 16.7 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.6% to 3.1% (+3.7% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 78th percentile. MRS_5 at 3.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.11% (CS: 79) | Strong |
| RSI_14 | 69.1 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 1.040x | Above |
| vs SMA50 | 1.087x | Above |
| vs SMA200 | 1.197x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $144.00
- **Stop Loss:** $138.88 (3.6% risk)
- **Target:** $151.68 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 269
- **Position Value:** $38,736.00
- **Portfolio %:** 38.74%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-22 (Est: $2.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.24 | $2.29 | +2.2% |
| 2025Q2 | $2.04 | $2.13 | +4.2% |
| 2025Q1 | $1.84 | $1.90 | +3.1% |
| 2024Q4 | $2.00 | $2.26 | +12.8% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*